Both in that dataset and in an independent dataset of melanoma samples derived from patients treated with anti-PD-1 therapy, AURKA, AURKB, and CDCA8 expression were higher in tumors that did not respond to immunotherapy. This evidence concerns the gene PDCD1 and melanoma.